Discussion on the potential impact of engineered bacteria in clinical settings
-
Dr. Philip McMillan and Dr. Shankara Shetty discussing the impact of engineered bacteria. • 0:05
-
Dr. Shetty’s focus on COVID-19 from an autoimmune perspective. • 0:20
-
Dr. Shetty’s interventions in South Africa to save patients’ lives. • 0:29
-
Concerns about the weaponization of bacteria and its potential impact. • 0:45
-
Dr. Shetty’s determination to save patients despite threats to his medical license. • 1:49
-
Dr. Shetty’s proactive approach in understanding and treating severe illness. • 2:05
-
Dr. Shetty’s analysis of clinical data and virus characteristics to develop treatment strategies. • 2:23
Insights on early treatment strategies for COVID-19 based on clinical observations and pathophysiological understanding
-
Clinical presentation led to understanding of immunological dysregulation in COVID-19. • 2:58
-
Recognized biphasic nature of illness and immune response involvement. • 3:12
-
Formulated treatment hypotheses based on known and unknown information. • 3:32
-
Published academic paper on observational and clinical findings in May-June 2020. • 4:00
-
Advocated for early treatment and pathophysiological research for effective COVID-19 management. • 4:24
-
Received recognition for accurate observations and treatment successes. • 5:11
Findings of early treatment negating the need for mRNA intervention in the pandemic
-
Discovery of a lab-made pathogen probability leading to critical findings on early treatment. • 5:35
-
Lack of acknowledgment shaping decisions and perspective on the pandemic narrative. • 7:03
-
Controversial statement on early treatment potentially reducing mortality and morbidity. • 7:40
-
Suggestion that mRNA intervention rush to market could have been unnecessary with early treatment solution. • 8:03
-
Importance of safety and efficacy in developing a strategy post early treatment confirmation. • 8:10
-
The end goal of negating mortality and morbidity to allow time for appropriate strategy development. • 8:15
-
Significance of the final point in the May 2020 article on potential solutions without additional interventions. • 8:21
Discussion on controversial scientific article, immunity against pathogens, and hope for understanding morbidity
-
Controversial scientific article led to hot water due to vaccine statement. • 8:37
-
Consulted peers who praised the scientific article but advised against vaccine mention. • 9:22
-
Discussion on serious clinical implications may not be welcomed by all. • 10:03
-
Viewers encouraged to follow the link for the full discussion due to sensitivity of some content. • 10:11
-
Dr. Shetty observed clinical patterns from the start, providing valuable insights. • 10:41
-
Hope given for understanding how pathogens cause morbidity and mortality in hosts. • 10:59
-
Immunity is remarkable in combating viruses and bacteria. • 11:09
Understanding host responses to pathogens is crucial for combating infections and improving future treatments
-
Immunity is developed through exposure in childhood, allowing us to ignore certain pathogens. • 11:16
-
Mortality and morbidity from infections are caused by host responses, not just the virulence of the pathogen. • 11:29
-
Virulence of a pathogen is its ability to trigger a serious host response, leading to host mortality. • 11:38
-
Understanding and curbing unusual host responses can help in dealing with any pathogen effectively. • 11:55
-
Knowledge about how different pathogens trigger cytokine storms is crucial for effective treatments. • 12:13
-
Continuing research in this area offers hope for better management of infections in the future. • 12:21
-
Stay informed and engaged in the research journey to contribute towards advancements in combating infections. • 12:28